RESEARCH

 

The research activities of BRTI are intended to be broad and encompass health problems (in both medical and veterinary fields) that are recognized as priority areas for research in the region. All kinds of research may receive BRTI support, provided that research activities adhere to national and international ethical principles, are relevant to health problems of the region and provide opportunities for local capacity building at individual, institutional and national levels.

 

 

RESEARCH STUDIES AT BRTI SINCE 1995

 Clinical trials of treatments for shigellosis, tuberculosis and HIV management

 Epidemiological studies of HIV, arboviral disease, avian influenza, rickettsial infections, malaria, tuberculosis and sexually transmitted diseases

 Genetic and Molecular studies in infectious disease, including genotyping, molecular epidemiology and research into the emergence and spread of resistance

 Clinical studies of meningitis, childhood pneumonia, pulmonary infections, HIV in adolescents and HIV co-infections

 Diagnostic evaluations for sexually transmitted infections, tuberculosis, malaria, maternally transmitted HIV and new technologies to quantify CD4 cells, and covering qualitative, quantitative and operational studies.

 Health systems research, including health policy research and research on health financing and human resources for health

 Community studies of HIV, child health, nutrition, psycho-social problems and educational opportunities for OVC

 Laboratory studies on cholera and other enteric diseases as well as sexually transmitted infections and antibiotic resistance

 Qualitative research on diagnostics and ethical issues in health research

During the last 20 years the BRTI has been responsible for the conduct of more than 80 internationally funded research studies. These studies have received funding from a variety of international agencies including the Wellcome Trust, the European Community and the European Developing Country Clinical Trials Partnership, the National Institutes of Health and Centers for Disease Control and Prevention, the Kellogg Foundation, the UK Department for International Development, the Royal Netherlands Embassy, the World Health Organisation, the International Atomic Energy Agency UNAIDS, UNFPA, UNICEF, the Global Fund to Fight AIDS, TB and Malaria, Plan International and others.